Gufic Biosciences Limited — Others, 31-05-2025: Copy of Newspaper Publication

Gufic Biosciences Limited has announced a board meeting to consider the financial results for the quarter and half-year. The audited standalone and consolidated results reflect steady operations, with total revenue at Rs. 82.09 Cr consolidated and Rs. 78.07 Cr standalone for the year. Net profit after tax stood at Rs. 6.72 Cr consolidated and Rs. 6.55 Cr standalone. Earnings per share were Rs. 2.07 consolidated and Rs. 2.02 standalone on a Rs. 10 equity share, indicating stable profitability and consistent performance.